296 related articles for article (PubMed ID: 15649192)
21. Response of vitiligo to narrowband ultraviolet B and oral antioxidants.
Elgoweini M; Nour El Din N
J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407
[TBL] [Abstract][Full Text] [Related]
22. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
23. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients.
Percivalle S; Piccinno R; Caccialanza M; Forti S
Pediatr Dermatol; 2012; 29(2):160-5. PubMed ID: 22329609
[TBL] [Abstract][Full Text] [Related]
24. Letter: Association of targeted intense pulse light system UVA1-UVB and fluticasone in the treatment of vitiligo: Prospective study of 10 patients.
Coelho JD; Ferreira A
Dermatol Online J; 2010 Mar; 16(3):15. PubMed ID: 20233572
[TBL] [Abstract][Full Text] [Related]
25. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
[TBL] [Abstract][Full Text] [Related]
27. [Phototherapy with UV-B in vitiligo].
Köster W; Wiskemann A
Z Hautkr; 1990 Nov; 65(11):1022-4, 1029. PubMed ID: 2080652
[TBL] [Abstract][Full Text] [Related]
28. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
29. Narrowband UVB phototherapy in skin conditions beyond psoriasis.
Gambichler T; Breuckmann F; Boms S; Altmeyer P; Kreuter A
J Am Acad Dermatol; 2005 Apr; 52(4):660-70. PubMed ID: 15793518
[TBL] [Abstract][Full Text] [Related]
30. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea.
Krüger C; Smythe JW; Spencer JD; Hasse S; Panske A; Chiuchiarelli G; Schallreuter KU
Acta Derm Venereol; 2011 Mar; 91(2):152-9. PubMed ID: 21240455
[TBL] [Abstract][Full Text] [Related]
31. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
32. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
33. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
[TBL] [Abstract][Full Text] [Related]
34. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
Lahiri K; Malakar S; Sarma N; Banerjee U
Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
[TBL] [Abstract][Full Text] [Related]
35. Identification of categories at risk for high quality of life impairment in patients with vitiligo.
Sampogna F; Raskovic D; Guerra L; Pedicelli C; Tabolli S; Leoni L; Alessandroni L; Abeni D
Br J Dermatol; 2008 Aug; 159(2):351-9. PubMed ID: 18565189
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
[TBL] [Abstract][Full Text] [Related]
37. Vitiligo: new and emerging treatments.
Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
[TBL] [Abstract][Full Text] [Related]
38. Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo.
Murase JE; Koo JY; Berger TG
J Am Acad Dermatol; 2010 Apr; 62(4):710-1. PubMed ID: 20227588
[No Abstract] [Full Text] [Related]
39. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study.
Wind BS; Kroon MW; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Meesters AA; Bos JD; Wolkerstorfer A
Br J Dermatol; 2010 May; 162(5):1142-4. PubMed ID: 20199553
[No Abstract] [Full Text] [Related]
40. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
